IMMUNE CEO ANNOUNCES NEW OPERATIONAL LEADERSHIP TEAM Elliott Goldstein, MD, Joins as Chief Medical Officer; Eugene Williams Joins as Chief Operating Officer

2.04.2014
|

IMMUNE CEO ANNOUNCES NEW OPERATIONAL LEADERSHIP TEAM

Elliott Goldstein, MD, Joins as Chief Medical Officer; Eugene Williams Joins as Chief Operating Office

 

NEW YORK and HERZLIYA, Israel, April 2, 2014 — Immune Pharmaceuticals Inc. (OTCQX IMNP and NASDAQ OMX First North Premier: IMNP) announced today the addition of two new senior members to its management team.

Elliot Goldstein, MD, joins as Chief Medical Officer. Dr. Goldstein brings a unique track record in the clinical, regulatory and commercial development of new pharmaceuticals. Dr. Goldstein began his career with Sandoz Pharmaceuticals (now Novartis), a fourteen-year period on drug development in France, Basel, Switzerland Global Headquarters, including as Head of Clinical R&D in the United States. He subsequently held positions as SVP of Strategic Product Development at SmithKline Beecham (now GSK), CEO of British Biotech (Oxford, UK), Chief Operating Officer and Chief Medical Officer of Maxygen, and President and CMO of a startup biotech devoted to development of biosimilar monoclonal antibodies. Dr. Goldstein holds an M.D. from the University Aix-Marseille II, Marseille, France, and a B.Sc. from McGill University, Montreal.

Eugene Williams joins as Chief Operating Officer. Mr. Williams is a former SVP at Genzyme, with senior roles integrating commercialization, drug development, and deal making. He is also an entrepreneur, as the founder and director of Adheris, which became the largest company in the patient adherence area. He was previously a strategy consultant at Bain and Corporate Decisions Inc. (a Bain Spin off, now part of Oliver Wyman), where he was co-Head of Healthcare and spent extensive time on speeding and improving the drug development process and on commercialization strategies. Mr. Williams was most recently the CEO of Dart Therapeutics, an Orphan Disease drug development company. Mr. Williams holds a B.A. from Harvard University and an M.B.A. from Harvard Business School.

 

“We are very happy to welcome Dr. Elliot Goldstein and Mr. Eugene Williams to our senior management team,” said Immune Pharmaceuticals’ CEO, Dr. Daniel Teper. “Following on our successful fund raising in March of this year, we are building a strong management team with the experience and vision to capitalize on our leading assets in the field of personalized medicine. Both Elliot and Eugene have a proven track record as innovators, and as senior leaders in very successful pharma and biotech companies. They bring significant experience in the disease areas which we have prioritized for our lead assets – rare diseases, autoimmune diseases, and oncology.”

 

 

About Immune Pharmaceuticals Inc.

 

Immune Pharmaceuticals Inc. applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is in clinical development for moderate to severe ulcerative colitis and Crohn’s Disease as well as bullous pemphigoid, an orphan auto-immune dermatological condition, Immune licensed worldwide rights for systemic indications of bertilimumab from iCo Therapeutics (TSX: ICO; OTCQX: ICOTF) in June 2011, while iCo retained rights to all ophthalmic indications. iCo originally licensed the exclusive world-wide rights to bertilimumab in 2006 from MedImmune, the Global Research and Development Arm of AstraZeneca. Immune’s pipeline also includes NanomAbs®, antibody nanoparticle conjugates, for the targeted delivery of chemotherapeutics and Amiket™, a Neuropathic Pain drug candidate ready for Phase III. Amiket has received Fast Track designation for chemotherapy induced neuropathic pain and Orphan Drug Designation for Post Herpetic Neuralgia.

 

For more information, visit Immune’s website at www.immunepharmaceuticals.com, the content of which is not a part of this press release.

 

Erik Penser Bankaktiebolag is engaged as Immune´s Certified Adviser on NASDAQ OMX First North Premier.

 

Forward-Looking Statements

 

This news release and any oral statements made with respect to the information contained in this news release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You are urged to consider statements that include the words “may,” “will,” “would,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plans,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal” or the negative of those words or other comparable words to be uncertain and forward-looking. Such forward-looking statements include statements that express plans, anticipation, intent, contingency, goals, targets, future development and are otherwise not statements of historical fact. These statements are based on our current expectations and are subject to risks and uncertainties that could cause actual results or developments to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Factors that may cause actual results or developments to differ materially include, but not limited to: the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern; the risks associated with our ability to continue to meet our obligations under our existing debt agreements; the risk that we will not be able to find a partner to help conduct the Phase III trials for AmiKet™ on attractive terms, a timely basis or at all; the risk that we will not obtain approval to market and commercialize any of our product candidates; the risks associated with dependence upon key personnel; the risks associated with reliance on collaborative partners and others for further clinical trials, development, manufacturing and commercialization of our product candidates; the cost, delays and uncertainties associated with our scientific research, product development, clinical trials and regulatory approval process; our history of operating losses since our inception; the highly competitive nature of our business; risks associated with litigation; risks associated with our ability to protect our intellectual property; risks associate with our ability to raise additional funds; and our liquidity. These factors and other material risks are more fully discussed in our periodic reports, including our reports on Forms 8-K, 10-Q and 10-K and other filings with the U.S. Securities and Exchange Commission. You are urged to carefully review and consider the disclosures found in our filings which are available at www.sec.gov or at www.immunepharmaceuticals.com. You are cautioned not to place undue reliance on any forward-looking statements, any of which could turn out to be wrong due to inaccurate assumptions, unknown risks or uncertainties or other risk factors. We expressly disclaim any obligation to publicly update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

 

Immune Pharmaceuticals Inc.:

708 Third Avenue, Suite 210

New York, NY 10017

Anna Baran, Director of Investor Relations and Corporate Communications

Tel: (646) 937-1941

anna.baran@immunepharma.comnewmanagement

 

Download PDF

Comments are closed.

order requip canada buy generic Requip australia Requip online 0,5mg Requip 0,5 mg without prescription mail order requip non prescription arimidex Arimidex generic online pharmacy arimidex no prescription Requip online australia where to buy requip buy Arimidex visa online buy cheap arimidex buy Arimidex 1mg no prescription Arimidex no prescription no prescription Maxalt where to buy Maxalt online purchase Maxalt online where to buy Maxalt by cod buy Maxalt without a rx buy no online rx Rizatriptan generic Maxalt prices buy Maxalt online now Maxalt mexico maxalt order online buy Maxalt Maxalt to buy buy Maxalt without doctor pharmacy Maxalt comprar Maxalt generico buy maxalt cheap online online maxalt purchase uk buy Maxalt buy Maxalt epharmacist Rizatriptan 10 mg el Maxalt generico Maxalt buy on line Maxalt side effects buy Maxalt no prescription low cost buy Maxalt no rx Maxalt wholesale Maxalt capsule buying Maxalt buy on line Maxalt order buy Maxalt online where can i buy Maxalt without prescription uk order maxalt prescription Maxalt Maxalt cheap mexican buy Requip internet Requip no rx in us Requip 0,5 mg no prescription Requip without prescription buy generic Requip canada buy Requip best how to order Arimidex online without a prescription buy Arimidex buy Requip capsules 1 mg Arimidex strattera online buying Requip online without prescription purchase generic Requip Arimidex online no prescription 1 mg buy Requip online without prescription from canada Requip purchase without perscripotion arimidex 1mg side effects purchase Requip buy Requip online canada buy Requip from the uk how to order Arimidex online without a prescription purchase Cytotec no visa without prescription uk Cytotec cheap Cytotec buy online Cytotec Cytotec shipped by cash on delivery buy next day Cytotec Cytotec espana Cytotec online no rx overnight buy Cytotec mastercard purchase online Cytotec without rx order generic Cytotec Cytotec no prescription Cytotec online purchase Cytotec orderd online without prescription want to buy Cytotec in usa seroquel for sale buy cheap generic seroquel online canada pharmacy no prescription how to purchase seroquel seroquel generic walmart getting seroquel without doctor buy seroquel pills no prescription buy seroquel without doctor buy 25 mg seroquel uk seroquel no script where can i buy seroquel over the counter buy Seroquel visa buy generic arimidex cheap generic requip no prescription overnight no prescription requip to buy requip order requip uk buy requip brand cheap generic requip no prescription requip in usa buy requip no prescription needed buy generic arimidex buy atarax fedex buy requip online australia buy tenormin non prescription buy revia with visa tenormin online without a prescription tenormin tablets 50 mg no prescription australia buy keflex online uk where can i get revia without a prescription atarax order online buy requip 0.5mg uk pharmacy Maxalt buy Maxalt no prescription low cost buy maxalt online pills buy Maxalt Online buy Requip cash on delivery Isotretinoin online sale without prescription Cytotec with repronex Arimidex order online Seroquel prescription cost Finasteride overnight fed ex no prescription Clomiphene order online can you buy Furosemide online Arimidex overnight without prescription buy Cytotec without a perscription buy Tamoxifen no prescription online